Delivery Order SPE2DB20D3103-SPE2DB24FL7Z3
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 18, 2024. The $20,757.04 firm fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,229.78 for the pharmaceutical product Icosapent Ethyl 1 gram capsules. The contract was awarded by the Defense Logistics Agency (DLA) on January 20, 2023, with a completion date of January 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
- This federal contract award, valued at $1,555.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract is for the delivery of Icosapent Ethyl 1 gram capsules, a pharmaceutical product used for cardiovascular health. This...
- This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
- This federal contract award is for the delivery of Icosapent Ethyl 0.5 GM capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,227.39 and a completion date of June 2, 2023. It is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,209.19 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product, with a period of performance through August 1, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,288.85 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a medication used for cardiovascular health. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,115.61 firm fixed price delivery order is for the supply of 120-count bottles of the pharmaceutical product Icosapent Ethyl 1 gram capsules. The award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corporation with DLA,...
- This federal contract award, valued at $1,232.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $14,087.56, is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. The contract has a period of performance through September 6, 2023 and is structured as a firm fixed-price delivery order. The award was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL7Z3Delivery Order
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,529.08 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 120 count capsules of Icosapent Ethyl 1 gram, a prescription medication. The award has a completion date of December 6, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award does not have a set-aside designation, indicating it was competitively awarded.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/5/23 |